卫生组织将糖尿病和肥胖症药品列入基本药品清单,以增加穷国的药品供应。 WHO adds diabetes and obesity drugs to essential medicines list to boost access in poor countries.

世界卫生组织(世卫组织)在其基本药品清单中增加了诸如Ozempic和Mounjaro等糖尿病和肥胖药物,目的是增加低收入国家的药品供应。 The World Health Organization (WHO) has added diabetes and obesity drugs like Ozempic and Mounjaro to its essential medicines list, aiming to boost access in low-income countries. 该清单现在包括523种成人药品和374种儿童药品,旨在确保在正常运作的卫生系统中提供这些药品。 The list, which now includes 523 medicines for adults and 374 for children, is designed to ensure availability in functioning health systems. 卫生组织还鼓励专利到期后采用更便宜的通用版本,以进一步改善获取机会。 The WHO also encourages cheaper generic versions upon patent expiration to further improve access.